China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Regulation of Metabolites by Gut Microbiota Influences the Efficacy of Bevacizumab in Treating Colorectal Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130922
Registration Time: 2026/08/26
Type: Observational study
Primary Sponsor: Shanghai Tenth People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=273759
Published by HT Digital Content Services with permission from Health Daily Digest....